CMCSA
55
-2
UNM
70
2
MRO
50
11
SBUX
36
4
MU
56
-3
HPE
44
-2
LYB
41
4
URI
63
3
EQT
57
3
MCD
46
-3
MTCH
44
-2
BIIB
45
-3
URBN
60
-3
CI
49
3
FOX
50
2
NKE
39
2
UHS
60
-3
FE
53
-2
ALLE
37
-4
DD
67
6
CMCSA
55
-2
UNM
70
2
MRO
50
11
SBUX
36
4
MU
56
-3
HPE
44
-2
LYB
41
4
URI
63
3
EQT
57
3
MCD
46
-3
MTCH
44
-2
BIIB
45
-3
URBN
60
-3
CI
49
3
FOX
50
2
NKE
39
2
UHS
60
-3
FE
53
-2
ALLE
37
-4
DD
67
6
Financhill
Back

Cytokinetics 10K Form

Sell
38

CYTK
Cytokinetics

Last Price:
59.57
Seasonality Move:
8.8%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-10 10Q CYTK/Cytokinetics Quarterly
2023-11-03 10Q CYTK/Cytokinetics Quarterly
2023-08-03 10Q CYTK/Cytokinetics Quarterly
2023-05-05 10Q CYTK/Cytokinetics Quarterly
2022-11-04 10Q CYTK/Cytokinetics Quarterly
2022-08-05 10Q CYTK/Cytokinetics Quarterly

Receive CYTK News And Ratings

See the #1 stock for the next 7 days that we like better than CYTK

CYTK Financial Statistics

Sales & Book Value

Annual Sales: $7.53M
Cash Flow: $-129.51M
Price / Cash Flow: 0
Annual Sales: $-3.78
Price / Book: 0

Profitability

EPS (TTM): -5.40000
Net Income (TTM): $-530.6M
Gross Margin: $-322.59M
Return on Equity: 0%
Return on Assets: -65.62%

Cytokinetics Earnings Forecast

Key Cytokinetics Financial Ratios

  • The Gross Profit Margin over the past 18 years for CYTK is -4,284.10%.
  • The Selling, General & Administrative Expenses for CYTK have been equal to 2,305.60% of Gross Profit Margin.
  • The Research & Development expenses have been 227.10% of Revenue.
  • The Interest Expense is -10.96% of Operating Income.
  • The Net Earning history of CYTK is -6,988.63% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 12 years.

Cytokinetics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: CYTK
CUSIP: 23282W
Website: cytokinetics.com

Debt

Debt-to-Equity Ratio: -1.56
Current Ratio: 7.19
Quick Ratio: 6.98

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

CYTK Technical Analysis vs Fundamental Analysis

Sell
38
Cytokinetics (CYTK) is a Sell

Is Cytokinetics a Buy or a Sell?

  • Cytokinetics stock is rated a Sell
    The current Cytokinetics [CYTK] share price is $59.53. The Score for CYTK is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.